By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Full steam ahead at PIER 4

opening ceremony at Pier 4 © Government of the Federal Province of Upper Austria/Grilnberger

PIER 4 sees itself as a free zone for industry, developers and founders, a dock on which flagships of Austrian industry can anchor in order to load valuable freight, namely ideas, solutions and prototypes for industry of tomorrow. The companies Amag, ELIN, Energie AG, Fabasoft, Lenzing AG, Miba and Primetals Technologies are among the firms on board. The initiative hopes for promising proposals in areas such as smart materials, artificial intelligence, digitalization and e-mobility.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • ABA's Open Day 2021: Austria - Your ICT and Innovation Hub in the Heart of Europe

    11 March 2021/ 09.00am + 05.00 pm, Online Conference

  • Meet us @ International Machinery Forum 2021 - The Factory of Tomorrow

    11.03 - 12.03 2021, Online Conference

Austria Map

Find the perfect location for your company

Thanks to its central location, excellent infrastructure and high quality staff, Austria is one of the key locations for ZTE Corporation and HQ for the Eastern Europe Region in general.

ZTE Austria

logo zte
More testimonials

news from the business location Austria

OMV and Kommunalkredit invest in the production of green hydrogen

The Austrian oil and gas company OMV and Kommunalkredit Austria AG (Kommunalkredit) have announced a joint investment in the construction of Austria’s largest electrolysis plant to be located in the OMV Schwechat Refinery.

Evotec SE

Evotec is an active substance research company which rapidly presses ahead with innovative product approaches on the basis of development partnerships with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.

More news All blog posts